Extendicare Stock Price on May 28, 2024
EXE Stock | CAD 10.38 0.14 1.37% |
Below is the normalized historical share price chart for Extendicare extending back to March 18, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Extendicare stands at 10.38, as last reported on the 24th of December, with the highest price reaching 10.43 and the lowest price hitting 10.22 during the day.
If you're considering investing in Extendicare Stock, it is important to understand the factors that can impact its price. Extendicare appears to be not too volatile, given 3 months investment horizon. Extendicare secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Extendicare, which you can use to evaluate the volatility of the firm. Please utilize Extendicare's Downside Deviation of 1.4, mean deviation of 1.01, and Coefficient Of Variation of 864.56 to check if our risk estimates are consistent with your expectations.
At this time, Extendicare's Total Stockholder Equity is very stable compared to the past year. As of the 24th of December 2024, Common Stock Shares Outstanding is likely to grow to about 93.4 M, while Other Stockholder Equity is likely to drop about 12.4 M. . At this time, Extendicare's Price Earnings Ratio is very stable compared to the past year. As of the 24th of December 2024, Price Book Value Ratio is likely to grow to 7.29, while Price To Sales Ratio is likely to drop 0.43. Extendicare Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 8.3785 | 50 Day MA 9.8802 | Beta 1.276 |
Extendicare |
Sharpe Ratio = 0.1299
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | EXE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
1.53 actual daily | 13 87% of assets are more volatile |
Expected Return
0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Extendicare is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Extendicare by adding it to a well-diversified portfolio.
Price Book 7.5184 | Enterprise Value Ebitda 7.3043 | Price Sales 0.6157 | Shares Float 82.6 M | Wall Street Target Price 10.5 |
Extendicare Valuation on May 28, 2024
It is possible to determine the worth of Extendicare on a given historical date. On May 28, 2024 Extendicare was worth 7.26 at the beginning of the trading date compared to the closed value of 7.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Extendicare stock. Still, in general, we apply an absolute valuation method to find Extendicare's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Extendicare where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Extendicare's related companies.
Open | High | Low | Close | Volume | |
7.27 | 7.30 | 7.24 | 7.29 | 34,700 | |
05/28/2024 | 7.26 | 7.28 | 7.14 | 7.17 | 118,700 |
7.11 | 7.19 | 7.09 | 7.12 | 79,500 |
Backtest Extendicare | | | Extendicare History | | | Extendicare Valuation | Previous | Next |
Extendicare Trading Date Momentum on May 28, 2024
On May 29 2024 Extendicare was traded for 7.12 at the closing time. The maximum traded price for the trading interval was 7.19 and the lowest daily price was 7.09 . The daily volume was recorded at 79.5 K. The volume of trading on 29th of May 2024 played a part in the next trading day price drop. The overall trading delta to the next closing price was 0.70% . The overall trading delta to the closing price today is 2.23% . |
Extendicare Fundamentals Correlations and Trends
By evaluating Extendicare's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Extendicare's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Extendicare financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Extendicare Stock history
Extendicare investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Extendicare is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Extendicare will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Extendicare stock prices may prove useful in developing a viable investing in Extendicare
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 85 M | 93.4 M | |
Net Income Applicable To Common Shares | 62.6 M | 36.1 M |
Extendicare Stock Technical Analysis
Extendicare technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Extendicare Period Price Range
Low | December 24, 2024
| High |
0.00 | 0.00 |
Extendicare cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Extendicare December 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Extendicare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Extendicare shares will generate the highest return on investment. By undertsting and applying Extendicare stock market strength indicators, traders can identify Extendicare entry and exit signals to maximize returns
Extendicare Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Extendicare's price direction in advance. Along with the technical and fundamental analysis of Extendicare Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Extendicare to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0964 | |||
Jensen Alpha | 0.1608 | |||
Total Risk Alpha | 0.1195 | |||
Sortino Ratio | 0.0998 | |||
Treynor Ratio | 1.5 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.